| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.23 | 2e-06 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |